Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Real-time Estimate Cboe BZX
Other stock markets
 01:33:32 2024-06-03 pm EDT 		5-day change 1st Jan Change
1.725 USD +1.47% Intraday chart for CytomX Therapeutics, Inc. -3.35% +11.61%
May. 28 Piper Sandler Upgrades CytomX Therapeutics to Overweight From Neutral, Adjusts Price Target to $3.50 From $2.25 MT
May. 09 BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Neutral

Neutral

Resistance 5.130 5.130 4.430
Spread/Res.-66.86%-66.86%-61.63%
Spread/Supp.+27.82%+27.82%+58.88%
Support 1.330 1.330 1.070

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Charts CytomX Therapeutics, Inc.